139. Development of cefiderocol resistance in an Enterobacter hormaechei strain following prolonged antibiotic exposure

Autor: Rachel Medernach, William J Moore, Sophia Nozick, Maha M Alamri, Kendall Kling, Michael G Ison, Qi Chao, Kelly E R Bachta, Nathaniel J Rhodes, Egon A Ozer, Alan R Hauser

Publikováno v: Open Forum Infectious Diseases. 9

Background Cefiderocol (FDC) is a novel antimicrobial agent used for multi-drug resistant Gram-negative pathogens. To date, reports of mutations in β-lactamase and siderophore complex genes have been described and may contribute to FDC resistance. T

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::743f5be7fda700737f726485f25d2189
https://doi.org/10.1093/ofid/ofac492.217

782. Infectious Complications of Lung Transplant for COVID-Associated Lung Injury (CALI)

Autor: Rebecca Osborn, Michael G Ison, Maha M Alamri

Publikováno v: Open Forum Infectious Diseases. 9

Background More than 200 orthotopic lung transplants (OLT) have been performed in the United States for patients (pts) with severe CALI. While some outcomes have been reported to generally be good, we conducted this study to describe the infectious o

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::41569b21ab73bd5010960321ae42f958
https://doi.org/10.1093/ofid/ofac492.043

Descriptive analysis of clinical and laboratory findings in relation to changes in SARS-CoV-2 viral dynamics and cyclic threshold: a retrospective, single center observational study in patients treated with Hydroxychloroquine/Azithromycin combination therapy

Autor: Maha M. Alamri, Edward B. Devol, Anwar B. Al-Otaibi, Faisal A. Albaiz, Mayyadah H. Alabdely, Sahar I. Althawadi, Maysoon S. Mutabagani, Fatimah S. Alhamlan, Fahad A. Alrabiah, Reem S. Almaghrabi

Publikováno v: F1000Research. 11:925

Background: Cases of undiagnosed pneumonia have emerged, and sequencing of respiratory samples indicated the presence of SARS-CoV-2 causing COVID-19. Patients with higher viral load and lower Ct values tend to have progressive disease and severe lung

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::b77aea7f22875a63a3bd27fd22e207d9
https://doi.org/10.12688/f1000research.28290.1

Infectious Complications of Lung Transplant for Coronavirus Disease 2019-Associated Lung Injury: A Single-Center Case-Control Cohort Study.

Autor: Osborn R; Division of Infectious Diseases, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA., Alamri M; Division of Infectious Diseases, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA., Tomic R; Division of Pulmonary and Critical Care Medicine, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA., Ison MG; Respiratory Diseases Branch, Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, Rockville, Maryland, USA.

Publikováno v: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2023 Jul 26; Vol. 77 (2), pp. 220-228.

Outcome of SARS-CoV-2 variant breakthrough infection in fully immunized solid organ transplant recipients.

Autor: Almaghrabi RS; Organ Transplant Center of Excellence, King Faisal Specialist Hospital and Research Center, Riyadh, Kingdom of Saudi Arabia., Alhamlan FS; Department of Infection and Immunity, King Faisal Specialist Hospital and Research Center, Riyadh, Kingdom of Saudi Arabia., Dada A; Department of Pathology and Laboratory Medicine, King Faisal Specialist Hospital and Research Center, Jeddah, Kingdom of Saudi Arabia., Al-Tawfiq JA; Infectious Disease Unit, Specialty Internal Medicine, Johns Hopkins Aramco Healthcare, Dhahran, Kingdom of Saudi Arabia; Infectious Disease Division, Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, USA; Infectious Disease Division, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, USA., Al Hroub MK; Department of Infection Control and Hospital Epidemiology, King Faisal Specialist Hospital and Research Center, Jeddah, Kingdom of Saudi Arabia., Saeedi MF; Department of Medicine, King Faisal Specialist Hospital and Research Center, Jeddah, Kingdom of Saudi Arabia., Alamri M; Department of Medicine, King Faisal Specialist Hospital and Research Center, Riyadh, Kingdom of Saudi Arabia., Alhothaly B; Department of Medicine, King Faisal Specialist Hospital and Research Center, Riyadh, Kingdom of Saudi Arabia., Alqasabi A; Department of Medicine, King Faisal Specialist Hospital and Research Center, Riyadh, Kingdom of Saudi Arabia., Al-Qahtani AA; Department of Infection and Immunity, King Faisal Specialist Hospital and Research Center, Riyadh, Kingdom of Saudi Arabia., Al-Omari A; Dr Sulaiman Al Habib Medical Group, Riyadh, Kingdom of Saudi Arabia; College of Medicine, AlFaisal University, Riyadh, Kingdom of Saudi Arabia., Alshukairi AN; Department of Medicine, King Faisal Specialist Hospital and Research Center, Jeddah, Kingdom of Saudi Arabia; College of Medicine, AlFaisal University, Riyadh, Kingdom of Saudi Arabia. Electronic address: abeer.alshukairi@gmail.com.

Publikováno v: Journal of infection and public health [J Infect Public Health] 2022 Jan; Vol. 15 (1), pp. 51-55. Date of Electronic Publication: 2021 Dec 04.